Literature DB >> 36192657

Revision paraesophageal hernia repair outcomes in patients with typical and atypical reflux.

Alex J Addo1, Ayobami M Fatunmbi2, Sanjhai L Ramdeen2, Andrew Broda3, Vladan Obradovic2, Anthony T Petrick2, David M Parker2.   

Abstract

BACKGROUND: Revision laparoscopic anti-reflux surgery (RLARS) is effective in alleviating the typical symptoms of gastroesophageal reflux disease (GERD). RLARS outcomes in patients with atypical GERD symptoms has not been well established. A composite Reflux Symptom Index (RSI) score greater than 13 indicates extraesophageal manifestation of pathological reflux. In this study, we analyzed the differences in quality-of-life (QOL) and perioperative outcomes between patients with atypical versus typical GERD who underwent RLARS.
METHODS: A retrospective review was conducted of a prospectively maintained database of patients with pathologic reflux who underwent RLARS from February 2003 to October 2019. The cohort was divided into two groups, those with typical versus atypical manifestations of GERD, as defined by their RSI score. Patients with a RSI score of  > 13 were assigned to the Atypical group and those ≤ 13 were assigned to the Typical group. Patient QOL outcomes were prospectively followed using the RSI survey. Significance was defined by p-value less than 0.05.
RESULTS: A total of 133 patients (Typical 61, Atypical 72) were included in the final analysis. The two groups were similar (p > 0.05) in mean age (58.1 ± 13.3 vs. 55.3 ± 15.5 years), body mass index (29.6 ± 5.0 vs. 30.3 ± 5.4), female sex distribution (60.7% vs. 59.7%) and age adjusted Charlson score (1.76 ± 1.58 vs. 1.98 ± 1.94). The Typical group had a higher frequency of type III hiatal hernia (62.3% vs. 29.2%) and Collis gastroplasty (29.5% vs. 5.6%). The groups had similar rates of partial and complete fundoplication with similar median length of stay (Typical: 3.0 ± 3.4 days vs. Atypical: 2.4 ± 1.7 days). After a mean follow-up of 30.2 ± 33.6 months, both groups reported similar rates of improvement in RSI outcome from baseline (58.1% vs 43.3%, p = .149). However, the RSI outcome at the latest follow-up for the Typical group was significantly better than the Atypical group after RLARS (2.8 ± 5.3 vs. 15.9 ± 11.1, respectively).
CONCLUSION: Patients who undergo revision paraesophageal hernia repair with objective findings of GERD and subjective complaints of atypical reflux symptoms may show long-term improvement in QOL outcomes. However, these results are contingent on proper patient selection and a thorough work-up for pathological reflux in this population. Further research is needed to determine universal diagnostic criteria to assist in the early detection and surgical treatment of patients with atypical GERD.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Year:  2022        PMID: 36192657     DOI: 10.1007/s00464-022-09635-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  21 in total

Review 1.  Gastroesophageal reflux disease: A review of surgical decision making.

Authors:  Maureen Moore; Cheguevara Afaneh; Daniel Benhuri; Caroline Antonacci; Jonathan Abelson; Rasa Zarnegar
Journal:  World J Gastrointest Surg       Date:  2016-01-27

2.  Long-term results after laparoscopic reoperation for failed antireflux procedures.

Authors:  B Dallemagne; M Arenas Sanchez; D Francart; S Perretta; J Weerts; S Markiewicz; C Jehaes
Journal:  Br J Surg       Date:  2011-06-28       Impact factor: 6.939

3.  Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review.

Authors:  Jerome R Lechien; Lee M Akst; Abdul Latif Hamdan; Antonio Schindler; Petros D Karkos; Maria Rosaria Barillari; Christian Calvo-Henriquez; Lise Crevier-Buchman; Camille Finck; Young-Gyu Eun; Sven Saussez; Michael F Vaezi
Journal:  Otolaryngol Head Neck Surg       Date:  2019-02-12       Impact factor: 3.497

4.  Chronic respiratory symptoms and occult gastroesophageal reflux. A prospective clinical study and results of surgical therapy.

Authors:  T R DeMeester; L Bonavina; C Iascone; J V Courtney; D B Skinner
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

Review 5.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Authors:  Anne F Peery; Seth D Crockett; Caitlin C Murphy; Jennifer L Lund; Evan S Dellon; J Lucas Williams; Elizabeth T Jensen; Nicholas J Shaheen; Alfred S Barritt; Sarah R Lieber; Bharati Kochar; Edward L Barnes; Y Claire Fan; Virginia Pate; Joseph Galanko; Todd H Baron; Robert S Sandler
Journal:  Gastroenterology       Date:  2018-10-10       Impact factor: 22.682

Review 6.  The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease.

Authors:  Ronnie Fass; Rosita Frazier
Journal:  Therap Adv Gastroenterol       Date:  2017-01-05       Impact factor: 4.409

7.  SAGES guidelines for the surgical treatment of gastroesophageal reflux (GERD).

Authors:  Bethany J Slater; Rebecca C Dirks; Sophia K McKinley; Mohammed T Ansari; Geoffrey P Kohn; Nirav Thosani; Bashar Qumseya; Sarah Billmeier; Shaun Daly; Catherine Crawford; Anne P Ehlers; Celeste Hollands; Francesco Palazzo; Noe Rodriguez; Arianne Train; Eelco Wassenaar; Danielle Walsh; Aurora D Pryor; Dimitrios Stefanidis
Journal:  Surg Endosc       Date:  2021-07-19       Impact factor: 4.584

Review 8.  Laryngopharyngeal Reflux and Atypical Gastroesophageal Reflux Disease.

Authors:  Caroline M Barrett; Dhyanesh Patel; Michael F Vaezi
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-01-22

9.  Validity and reliability of the reflux symptom index (RSI).

Authors:  Peter C Belafsky; Gregory N Postma; James A Koufman
Journal:  J Voice       Date:  2002-06       Impact factor: 2.009

10.  Comparison between the Reflux Finding Score and the Reflux Symptom Index in the Practice of Otorhinolaryngology.

Authors:  Heloisa Sobreira Nunes; José Antonio Pinto; Adma Roberta Zavanela; André Freitas Cavallini; Gabriel Santos Freitas; Fabiola Esteves Garcia
Journal:  Int Arch Otorhinolaryngol       Date:  2016-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.